Skip to main content
Fig. 5 | Cancer Nanotechnology

Fig. 5

From: Multifunctional nanocomposites DDMplusAF inhibit the proliferation and enhance the radiotherapy of breast cancer cells via modulating tumor-promoting factors and metabolic reprogramming

Fig. 5

Analysis of cell cycle distribution in DDMPlusAF and/or 6 Gy treated BCCs. Cell cycle charts of a distribution of MCF7 cells through the cell cycle phases and a representative histogram for the cell arrest percentage at various checkpoints, and b distribution of MDA-MB-321 cells through the cell cycle phases and a representative histogram for the cell arrest percentage at various checkpoints. Data are represented as mean ± SEM, a1p < 0.001, a2p < 0.01, a3p < 0.05 vs. Control group; b1p < 0.001, b2p < 0.01, b3p < 0.05 vs. DDMPlusAF group; c1p < 0.001, c2p < 0.01, c3p < 0.05 vs. 6 Gy group. Control group is MCF-7 or MDA cells

Back to article page